Hospital-based Home Care for Children With Cancer
1 Month
18 Years
Both
Neoplasms, Children
Trial Information
Hospital-based Home Care for Children With Cancer
Hospital-based home care for children with cancer is widely used but controlled studies are
relatively rare and the evidence base is limited. This prospective non-randomized controlled
intervention study aimed to evaluate hospital-based home care for children with cancer.
A hospital-based home care program was conducted August 2008 - December 2009. Participants
were children with cancer and their parents. The intervention group received part of their
therapy, such as intravenous chemotherapy and antibiotics, as home care by a hospital-based
home care nurse with paediatric-oncology experience. Children in the control group received
all their treatment at the hospital.
Fifty-one children between 0 and 18 years were included in the home care program, and 47
children were included in the control group. After each home visit the parents answered a
questionnaire. The results from 657 questionnaires showed that 100% were very satisfied or
satisfied with home care and all would choose home care again, if offered as an option.
There were no deaths or adverse effects of intravenous chemotherapy or antibiotics. A cost
analysis based on the expenses associated with home care in correlation with standard cost
of inpatient admissions and outpatient visits showed that the hospital-based home care
programme was economically equal. The children's and the families' quality of life may be
enhanced. The results indicate that the hospital-based home care program is safe,
economically neutral and the parents' satisfaction with the program is major.
Inclusion Criteria:
- Clinical diagnosis of cancer
- First-line treatment with intravenous therapy with a curative intent
- Have not received a haematopoietic stem cell transplantation
- Child and parent(s) speak and read Danish
Exclusion Criteria:
- End-of-life treatment
- Critical medical condition
Type of Study:
Interventional
Study Design:
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Number of adverse events
Outcome Description:
At each home visit, the hospital-based home care nurse recorded details on the HBHC visits and safety according to the mandatory hospital guidelines for registrations of adverse events such as acute deteriorations of the general condition, and any medical errors.
Outcome Time Frame:
17 months
Safety Issue:
Yes
Principal Investigator
Helena Hansson, MSc
Investigator Role:
Principal Investigator
Investigator Affiliation:
Rigshospitalet, Denmark
Authority:
Denmark: National Board of Health
Study ID:
959584438
NCT ID:
NCT01538706
Start Date:
August 2008
Completion Date:
October 2010
Related Keywords:
- Neoplasms
- Children
- Hospital-based home care
- Pediatric oncology
- Neoplasms
Name | Location |
|---|
